期刊文献+

环氧化酶-2及其抑制剂,现在何处?又应走向何方? 被引量:1

COX-2 and COX-2 inhibitor, where are we? where do we go?
下载PDF
导出
摘要 本文回顾环氧化酶-2(COX-2)抑制剂的发展史和分析新的筛选方法:如平衡抑制剂对COX-1/COX-2的选择性,寻找双靶点或多靶点的抑制剂。在计算机辅助药物设计中结合更多的灵活的动力学原理,在天然分子的基础上设计新的药物分子,辅以脂质体包裹剂型实现药物靶向投递,以图研究出新一代更为安全的COX-2抑制剂来预防、控制癌症和其他疾病。 This review is to discuss the COX-2 inhibitor screening from cell based bioassay and computer-based molecular docking technique towards more balanced inhibition of COX-I/COX-2, multiple-target inhibitors, and alternative choice of delivery, especially liposome encapsulated nanoparticles, in order to exploit new generation of safer COX-2 inhibitors for prevention and medication of cancer and other diseases.
出处 《生命科学》 CSCD 2008年第1期76-80,共5页 Chinese Bulletin of Life Sciences
关键词 选择性环氧化酶-2抑制剂 非甾体抗炎药 细胞凋亡 毛细血管生成 分予对接 脂质体 selective COX-2 inhibitor NSAID apoptosis angeogenesis molecular docking liposome
  • 相关文献

参考文献1

二级参考文献43

  • 1Xie WL, Chipman JG, Robertson DL, Erikson RL, Simmons DL.Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc Natl Acad Sci USA 1991; 88: 692-6.
  • 2Fu JY, Masferr JL, Seibert K, Raz A, Needleman P. The induction and suppression of prostaglandin h2 synthase (cyclooxygenase)in human monocytes. J Biol Chem 1990; 265: 16737-40.
  • 3Luo C, Laine JVO, Ylinen L, Teros T, Maikinen M, Ristimaiki A,et al. Expression of cyclooxygenase-2 in intestinal goblet cells of prediabetic non-obese diabetic mice. Acta Physiol Scand 2002;174: 265-74.
  • 4Luo C, Trauss L, Treng T, Ristimaiki A, Santti R. Constant exprkession of cyclooxygenase-2 gene in the lower urinary tract and prostate of the male rats treated with estrogen. Z Naturforsch2001 ; 56C: 455-63.
  • 5Gilroy DW, Colville-Nash PR, Willis D, Chivers J, Paul-Clark M J, Willoughby DA. Inducible cyclooxygenase may have antiinflammatory properties. Nat Med 1999; 5: 621-2.
  • 6Topoi EJ. Arthritis Medicines and Cardiovascular Events: "House of Coxibs". J Am Med Assoc 2005; 293: 366-8.
  • 7Warner TD, Mitchell 3A. Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic. FASEB J 2004; 18: 790- 804.
  • 8Kraemer SA, Meade EA, DeWitt DL. Prostaglandin endoperoxide synthase gene structure: identification of the transcriptional start site and 5'-flanking regulatory sequences, Arch Biochem Biophys 1992, 293, 391-400.
  • 9Colville-Nash PR, Gilroy DW. Potential adverse effects of cyclooxygenase-2 inhibition: evidence from animal models of inflammation. BioDrugs 2001 ; 15: 1-9.
  • 10Onoe Y, Miyaura C, Kaminakayashiki T, Nagai Y, Noguchi K,Chen QR, et al. IL-13 and IL-4 inhibit bone resorption by suppressing cyclooxygenase-2-dependent prostaglandin synthesis in osteoblasts. J Immunol 1996; 156: 758-64.

共引文献4

同被引文献28

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部